DRILS Mentioned in News for its Research Contribution on Covid..

Effectiveness of REGEN-COV antibody cocktail against the B.1.617.2 (delta) variant of SARS-CoV-2: A cohort study..

Monoclonal antibody therapy 100 pc prevents Covid severity and deaths

https://pubmed.ncbi.nlm.nih.gov/34719811/

https://www.thehindu.com/news/cities/Hyderabad/hyderabads-aig-hospitals-announce-results-of-monoclonal-antibody-therapy-for-covid-19/article37305381.ece

https://timesofindia.indiatimes.com/home/science/monoclonal-antibody-cocktail-effectively-neutralises-delta-variant-study/articleshow/87485147.cms

https://www.indiatoday.in/coronavirus-outbreak/story/monoclonal-antibody-therapy-prevents-severe-disease-death-in-covid-19-patients-reveals-study-1872490-2021-11-02

https://zeenews.india.com/india/breakthrough-in-covid-19-treatment-monoclonal-therapy-100-effective-in-preventing-death-claims-study-2407418.html/amp

TNIE Telangana on Twitter: “#JustIn | Dr D Nageshwar Reddy, Chairman of Asian Institute of Gastroenterology and @AIGHospitals Hospitals, #Hyderabad addressing the press on Monoclonal Antibodies at AIG hospitals in Hyderabad on Tuesday. Express Video | @meetsenbaga. @NewIndianXpress https://t.co/G3EsyMNYQl” / Twitter

https://telanganatoday.com/monoclonal-antibody-therapy-100-pc-prevents-covid-severity-and-deaths

https://www.eenadu.net/mukyamshalu/mainnews/general/2701/121225188